Find Your Resources
Treating trauma during COVID-19: Factors for adapting treatment to telehealth
Part two of this webinar series will address the differences in treatment approach when comparing telehealth and in-person delivery, address assessment and treatment concerns caused by environmental stressors such as COVID-19, and discuss the impact that relaxing quarantine and stay-at-home orders has on treatment.
Treating trauma during COVID-19: Treatment considerations amid social distancing
Learn how to make adjustments to adequately address patients with trauma or PTSD symptoms while being mindful of their unique needs, abilities, and self-care during social distancing
Treating depression during COVID-19: Building connections and increasing engagement
This presentation will address the challenges of activity scheduling and creating a cohesive group in light of the social distancing guidelines in place during the COVID-19 pandemic. Explore creative solutions and uncover values based behavioral activation assignments relating to the current health crisis.
Treating depression during COVID-19: Considerations for psychological and psychiatric treatment
Review behavioral activation theory and pharmacotherapy for depression, and gain an understanding of the benefits of a combined approach, in part one of this webinar series. Time will also be spent identifying necessary modifications for pharmacotherapy during COVID-19 and adaptations for behavioral activation, which are necessary when treatment is provided via telehealth.
Treating OCD during COVID-19: Addressing contamination-related fears
This presentation addresses the cognitive-behavioral treatment of contamination fears and associated washing and other compulsions in the midst of an international health crisis in which social distancing, avoidance of contaminated surfaces, and handwashing are strongly emphasized by the Centers for Disease Control as primary tools to prevent infection.
Treating OCD during COVID-19: Pharmacotherapy and combined treatments
This presentation will provide a review of empirically supported pharmacological interventions for OCD and address some of the unique challenges of delivering this treatment both alone and in combination with CBT via telepsychiatry.